Article
Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
Journal of lipid research - 1 Dec 2014
Obinata Hideru, Gutkind Sarah, Stitham Jeremiah, Okuno Toshiaki, Yokomizo Takehiko, Hwa John, Hla Timothy
Abstract excerpt
Sphingosine 1-phosphate receptor 1 (S1P₁), an abundantly-expressed G protein-coupled receptor which regulates key vascular and immune responses, is a therapeutic target in autoimmune diseases. Fingolimod/Gilenya (FTY720), an oral medication for relapsing-remitting multiple sclerosis, targets S1P₁ receptors on immune and neural cells to suppress neuroinflammation. However, suppression of endothelial S1P₁ receptors...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
